Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$11,927,146
+$1,122,185 QoQ
Shares Held
32,937
+7.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#493
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. AMGN ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
This page
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,927,146 | 32,937 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $10,804,961 | 30,709 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $9,797,697 | 29,934 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $8,160,659 | 28,918 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $7,639,185 | 27,360 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $8,207,473 | 26,344 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $6,689,586 | 25,666 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $7,820,358 | 24,271 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $7,370,383 | 23,589 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $6,400,611 | 22,512 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $5,498,013 | 19,089 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $4,858,374 | 18,077 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $257,987 | 1,162 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $245,134 | 1,014 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $261,852 | 997 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $224,723 | 997 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $251,815 | 1,035 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $239,401 | 990 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $374,800 | 1,666 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $350,021 | 1,646 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $419,006 | 1,719 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $230,398 | 926 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $189,684 | 825 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $167,237 | 658 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $155,195 | 658 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $131,774 | 650 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||